Navigation Links
Guide for US FDA-Regulated Organizations Now Available
Date:4/29/2010

“How to Avoid and Respond to Public FDA Criticisms—Form 483 Letters—for Temperature, Humidity and other Controlled Environments”

(Vocus) April 29, 2010 -- “How to Avoid and Respond to Public FDA Criticisms—Form 483 Letters—for Temperature, Humidity and other Controlled Environments” is now available from Veriteq (www.veriteq.com), a Vaisala company, a leader in FDA-compliant environmental monitoring, alarming, reporting and temperature/humidity technology. The 10-step Guide is designed to help the wide range of pharmaceutical processors, blood and tissue banks, clinical laboratories, medical device manufacturers, research hospitals, and other GxP facilities who may receive public criticism warning letters respond quickly and appropriately within the permitted 15-day window. Proper FDA 483 letter response is critical to both help in reputation repair and for real remediation actions to assure a quality process and patient safety.

FDA 483 letters are expected to increase this year, reflecting the FDA’s recent staff expansion and rewrite of the FDA 483 Letter rules to narrow response time to the new 15-day window.

Ken Appel, Veriteq Manager Regulated Markets, comments, "Veriteq is keenly aware of the great number of FDA-regulated companies that thought they were in full compliance but were not when it came to temperature monitoring. Since Veriteq offers the only monitoring system that ensures both gap-free records and accuracy in between calibration intervals we have always had customers who came to Veriteq because they were using inferior solutions. Customers are often disappointed over the failure of chart recorders or data loggers to record data during facility power outages, hold calibration accuracy of sensors or other equipment failure that had triggered negative FDA actions or product loss. If and when a company receives a Warning Letter it is a matter of public record listed on the FDA's web site. Veriteq's guide-"How to Avoid and Respond to Public FDA Criticisms-Form 483 Letters-for Temperature, Humidity and other Controlled Environments" will help quality departments that have received such public criticism regroup, but more importantly, will give some best-practice tips that will help FDA-regulated organizations avoid Warning Letters in the first place."

To obtain a copy of the Guide fill out the request form at http://www.veriteq.com/fda_response.htm or contact: Janice Bennett, Veriteq Marketing Manager, 800-683-8374 (or +1-604-273-6850 outside North America), FAX 604-273-2874.

About Veriteq

Veriteq Instruments (www.veriteq.com), a Vaisala company, provides environmental monitoring of temperature, humidity and other critical variables in controlled environments for regulated industries and other critical storage applications where product loss or audit failures are unacceptable. A network of independent data recorders equipped with industry-best 10-year batteries deliver monitoring, alarming and reporting with a continuous record of data, immune from power outages and network interruptions. Headquartered in Richmond, BC, with a worldwide distributor network Veriteq serves thousands of users, from Global 500 companies and major learning, standards and government institutions to mid-sized research and manufacturing organizations.

About Vaisala
Vaisala is a global leader in environmental and industrial measurement. Building on more than 70 years of experience, Vaisala contributes to a better quality of life by providing a comprehensive range of innovative observation and measurement products and services for meteorology, weather critical operations and controlled environments. Headquartered in Finland, Vaisala employs over 1400 professionals worldwide and is listed on the NASDAQ OMX Helsinki. www.vaisala.com For more information: Pirjo Kortteisto, Director, Cleanrooms & Chambers, tel. +358 40 7683 826, or Liisa Ahtiluoto, Communications Manager, tel. +358 40 730 7695

Please address editorial inquiries to Amy Munice, ALM Communications, alm(at)almcommunications(dot)com, +1-773-862-6800, (skype) ALMCommunications.

# # #

Read the full story at http://www.prweb.com/releases/Veriteq/FDA_483/prweb3937084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Enjoy Pregnancy Without Foot Pain: Foot and Ankle Surgeon Offers Guidelines
2. Expert Approved: FatWallet Guides Mother's Day Shoppers to the Best Deals Online
3. Review Panel Leaves Controversial Lyme Disease Guidelines Unchanged
4. Physical Activity Guidelines for Americans interpreted for practical use
5. New Guidelines Issued on Hormone Receptor Testing for Breast Cancer
6. EAU launches new and updated clinical guidelines for 2010
7. Community research guidelines set stage for real world scholarship
8. 'What Women Really Want In Bed' Is A Man's Guide To Giving Her The Sex She Wants
9. Docs Issue Guidelines for Drivers With Dementia
10. The CPM Resource Center launches Web-based clinical practice guidelines
11. Guided Meditation Made Available to Everyone for Stress Awareness Month
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Guide for US FDA-Regulated Organizations Now Available
(Date:2/10/2016)... ... February 10, 2016 , ... LaserShip, a regional parcel carrier that services the ... Eastern Michigan last Friday in order to aid in the Flint water crisis. In ... a facility located in Clio, only 15 miles away from Flint. , “We have ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand ... within Healthcare, recently partnered with Heart City Health Center to improve ... 23 years, Heart City Health Center has provided the Elkhart community with access ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... 10 ... Brand. There were three leading bottled water brand owners that topped the list as ... enhance connectivity and optimize conversion. The premier brand was Tibet 5100, a top notch ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... welcomes S.S. Nesbitt as the latest addition to its growing list of Partner ... locations throughout the Southeast, from Orlando to Huntsville and in between. , Harnessing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged to ... shows that the Goal Attainment Scale (GAS) captures 20% more change in outcomes ... more about the Goal Attainment Scale, Education Resources Inc. is offering a course ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... and PITTSBURGH, Feb. 10, 2016 Mylan N.V. (NASDAQ, ... quarter and year ended December 31, 2015. ... Full year adjusted total revenues of $9.45 billion, up ... year; GAAP total revenues of $9.43 billion. Excluding the ... markets specialty and branded generics business (the "EPD Business"), ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
Breaking Medicine Technology: